Nitric oxide and downstream second messenger cGMP and cAMP enhance adipogenesis in primary human preadipocytes

Cytotherapy

Volumn 12, Issue 4, 2010, Pages 547-553

  Hemmrich, Karsten ^a,b   Gummersbach, Caroline ^a   Paul, Nora Emilie ^a   Goy, Daniela ^a   Suschek, Christoph V ^a   Kröncke, Klaus Dietrich ^c   Pallua, Norbert ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

CAMP; CGMP; Differentiation; Human adipose tissue derived stem cells; Nitric oxide

Indexed keywords

CYCLIC AMP; CYCLIC GMP; NITRIC OXIDE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL TRANSPLANTATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE;

EID: 77954430538     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653241003695042     Document Type: Article

References (40)

1. Rossatti B. Revascularisation and phagocytosis in free fat autografts: an experimental study. Br J Plast Surg. 1960; 13:35-41.
2. Wellen KE, Hotamisligil GS. Infl ammation, stress, and diabetes. J Clin Invest. 2005;115:1111-1119
3. Hemmrich K, Thomas GP, Abberton KM, Thompson EW, Rophael JA, Penington AJ, et al. Monocyte chemoattractant protein-1 and nitric oxide promote adipogenesis in a model that mimics obesity. Obesity (Silver Spring). 2007;15:2951-2957
4. Thomas GP, Hemmrich K, Abberton KM, McCombe D, Penington AJ, Thompson EW, et al. Zymosan-induced infl ammation stimulates neo-adipogenesis. Int J Obes (Lond). 2008;32:239-248
5. Christopherson KS, Bredt DS. Nitric oxide in excitable tissues: physiological roles and disease. J Clin Invest. 1997;100: 2424-2429
6. Schindler H, Bogdan C. NO as a signaling molecule: effects on kinases. Int Immunopharmacol. 2001;1:1443-1455
7. Elizalde M, Ryden M, van Harmelen V, Eneroth P, Gyllenhammar H, Holm C, et al. Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res. 2000;41:1244-1251
8. Engeli S, Janke J, Gorzelniak K, Bohnke J, Ghose N, Lindschau C, et al. Regulation of the nitric oxide system in human adipose tissue. J Lipid Res. 2004;45:1640-1648
9. Choi JW, Pai SH, Kim SK, Ito M, Park CS, Cha YN. Increases in nitric oxide concentrations correlate strongly with body fat in obese humans. Clin Chem. 2001;47:1106-1109
10. Andersson K, Gaudiot N, Ribiere C, Elizalde M, Giudicelli Y, Arner P. A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo. Br J Pharmacol. 1999;126: 1639-1645
11. Hrabie JA, Arnold EV, Citro ML, George C, Keefer LK. Reaction of nitric oxide at the beta-carbon of enamines. A new method of preparing compounds containing the diazeniumdiolate functional group. J Org Chem. 2000;65:5745-5751
12. Pairault J, Green H. A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker. Proc Natl Acad Sci USA. 1979;76:5138-5142
13. Spiegelman BM, Ginty CA. Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell. 1983;35:657-666
14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254
15. Patrick CW Jr, Zheng B, Johnston C, Reece GP. Long-term implantation of preadipocyte-seeded PLGA scaffolds. Tissue Eng. 2002;8:283-293
16. Hemmrich K, von Heimburg D, Rendchen R, Di Bartolo C, Milella E, Pallua N. Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice to evaluate potential for soft tissue engineering. Biomaterials. 2005;26: 7025-7037
17. Stillaert FB, Di Bartolo C, Hunt JA, Rhodes NP, Tognana E, Monstrey S, et al. Human clinical experience with adipose precursor cells seeded on hyaluronic acid-based spongy scaffolds. Biomaterials. 2008;29:3953-3959
18. Nisoli E, Clementi E, Tonello C, Sciorati C, Briscini L, Carruba MO. Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures. Br J Pharmacol. 1998;125:888-894
19. Yan H, Aziz E, Shillabeer G, Wong A, Shanghavi D, Kermouni A, et al. Nitric oxide promotes differentiation of rat white preadipocytes in culture. J Lipid Res. 2002;43:2123-2129
20. Sciorati C, Nistico G, Meldolesi J, Clementi E. Nitric oxide effects on cell growth: GMP-dependent stimulation of the AP-1 transcription complex and cyclic GMP-independent slowing of cell cycling. Br J Pharmacol. 1997;122:687-697
21. Klein C. Nitric oxide and the other cyclic nucleotide. Cell Signal. 2002;14:493-498
22. Vila-Petroff MG, Younes A, Egan J, Lakatta EG, Sollott SJ. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res. 1999; 84:1020-1031
23. Uchida Y, Tsukahara F, Ohba K, Ogawa A, Irie K, Fujii E, et al. Nitric oxide mediates down regulation of lipoprotein lipase activity induced by tumor necrosis factor-alpha in brown adipocytes. Eur J Pharmacol. 1997;335:235-243 (Pubitemid 27450491)
24. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43:109-142
25. Ibrahimi A, Abumrad N, Maghareie H, Golia M, Shoshani I, Desaubry L, et al. Adenylyl cyclase P-site ligands accelerate differentiation in Ob1771 preadipocytes. Am J Physiol. 1999; 276:C487 - 96.
26. Nishikimi T, Iemura-Inaba C, Akimoto K, Ishikawa K, Koshikawa S, Matsuoka H. Stimulatory and inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/G(i) pathways in rat cultured adipocytes. Regul Pept. 2008.
27. Fox KE, Fankell DM, Erickson PF, Majka SM, Crossno JT Jr, Klemm DJ. Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2. J Biol Chem. 2006;281:40341-40353
28. Yang DC, Tsay HJ, Lin SY, Chiou SH, Li MJ, Chang TJ, et al. cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS ONE. 2008;3: e1540.
29. Galea E, Feinstein DL. Regulation of the expression of the infl ammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J. 1999;13:2125-2137
30. Collins S, Daniel KW, Petro AE, Surwit RS. Strain-specifi c response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology. 1997;138: 405-413
31. Danforth E Jr, Himms-Hagen JH. Obesity and diabetes and the beta-3 adrenergic receptor. Eur J Endocrinol. 1997;136: 362-365
32. Jobgen WS, Fried SK, Fu WJ, Meininger CJ, Wu G. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem. 2006;17:571-588
33. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL, McKnight GS. Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature. 1996;382:622-626
34. Petersen RK, Madsen L, Pedersen LM, Hallenborg P, Hagland H, Viste K, et al. Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac-and cAMP-dependent protein kinasedependent processes. Mol Cell Biol. 2008;28:3804-3816
35. Casimir DA, Ntambi JM. cAMP activates the expression of stearoyl-CoA desaturase gene 1 during early preadipocyte differentiation. J Biol Chem. 1996;271:29847-29853
36. Montolio M, Biarnes M, Tellez N, Escoriza J, Soler J, Montanya E. Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation. J Endocrinol. 2007;192:169-177
37. Szabolcs MJ, Ravalli S, Minanov O, Sciacca RR, Michler RE, Cannon PJ. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation. 1998;65:804-812 (Pubitemid 28160672)
38. Cooke JP. NO and angiogenesis. Atheroscler Suppl. 2003;4: 53-60.
39. Jun HW, Taite LJ, West JL. Nitric oxide-producing polyurethanes. Biomacromolecules. 2005;6:838-844
40. Pyriochou A, Beis D, Koika V, Potytarchou C, Papadimitriou E, Zhou Z, et al. Soluble guanylyl cyclase activation promotes angiogenesis. J Pharmacol Exp Ther. 2006;319:663-671